Agostinetto E

ORCID: 0000-0003-0295-7511 · 1 paper in corpus

2023

Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib.

Journal of clinical medicine ·doi:10.3390/jcm12051775

In clinical trials testing abemaciclib in patients with hormone-receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer, diarrhea is a very common adverse event (occurring in approximately 85% of patients, any grade). Nonethel…